Position in ABBV
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$45,036,514
+$6,453,571 QoQ
Shares Held
178,972
+0.9% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
3.14%
of 13F equity value
Holder Rank
#396
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Verity & Verity, LLC holds $179,692,626 across 7 Drug Manufacturers - General names. ABBV ranks #1 (25.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
178,972 | $45,036,514 | |
| 2 | AMGN |
Amgen Inc
|
104,299 | $37,768,753 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
272,652 | $34,446,853 | |
| 4 | PFE |
Pfizer Inc
|
1,338,533 | $32,231,874 | |
| 5 | JNJ |
Johnson & Johnson
|
115,000 | $29,206,549 | |
| 6 | NVS |
Novartis AG
|
3,453 | $541,154 | |
| 7 | MRK |
Merck & Co., Inc.
|
3,587 | $460,929 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $45,036,514 | 178,972 | Shares | Other | 2026-07-28 | |
| 2026-03-31 | $38,582,943 | 177,401 | Shares | Other | 2026-04-15 | |
| 2025-12-31 | $39,910,804 | 174,672 | Shares | Other | 2026-02-10 | |
| 2025-09-30 | $40,143,247 | 173,375 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $31,962,650 | 172,194 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $36,362,615 | 173,552 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $30,538,100 | 171,852 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $32,250,063 | 163,308 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $26,425,914 | 154,069 | Shares | Sole | 2024-09-16 | |
| 2024-03-31 | $27,493,275 | 150,979 | Shares | Sole | 2024-09-16 | |
| 2023-12-31 | $25,791,812 | 166,431 | Shares | Sole | 2024-11-07 | |
| 2023-09-30 | $24,538,853 | 164,624 | Shares | Sole | 2024-11-07 | |
| 2023-06-30 | $21,799,718 | 161,803 | Shares | Sole | 2024-11-07 | |
| 2023-03-31 | $23,130,324 | 145,136 | Shares | Sole | 2024-11-07 | |
| 2022-12-31 | $22,618,612 | 139,958 | Shares | Sole | 2023-01-11 | |
| 2022-09-30 | $18,020,108 | 134,268 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $19,983,244 | 130,473 | Shares | Sole | 2022-08-18 | |
| 2022-03-31 | $21,186,804 | 130,694 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $17,485,149 | 129,137 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $11,113,306 | 103,025 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $11,285,288 | 100,189 | Shares | Sole | 2021-09-20 | |
| 2021-03-31 | $10,863,772 | 100,386 | Shares | Sole | 2021-06-21 | |
| 2020-12-31 | $9,820,618 | 91,653 | Shares | Sole | 2021-01-12 | |
| 2020-09-30 | $7,211,372 | 82,331 | Shares | Sole | 2020-10-06 | |
| 2020-06-30 | $7,856,559 | 80,022 | Shares | Sole | 2020-07-14 | |
| 2020-03-31 | $5,944,648 | 78,024 | Shares | Sole | 2020-04-09 | |
| No filing history on record for this holder in this stock. | ||||||